hotspot -WSS

hotspot

author：fashion 2025-09-06 01:50:41 - browse：617

The experimental Alzheimer’s drug lecanemab, hailed after it slowed patients’ cognitive decline in a clinical trial, may have contributed to the death in June of a patient in the study, STAT has learned.

One investigator on the study flagged the death, noting it came after the patient experienced bleeding in the brain, and concluded it was related to the drug, according to documents obtained by STAT. Eisai, the drugmaker behind lecanemab, disagreed, pointing to other possible factors, including a series of setbacks in preceding months — multiple falls, a heart attack, a respiratory infection, and mini-stroke-like events.

Though still under investigation, the death suggests that new medicines to treat Alzheimer’s, like medicines to treat anything else, will come with their own side effects and costs. It also raises the importance of waiting for the full lecanemab data before drawing conclusions based on the positive press release put out by Eisai and its partner Biogen last month.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Microsoft strikes partnership with Duke Health to advance health AI

entertainment

hotspot

WSS

For BCIs, commercial hurdles may be bigger than scientific ones

Iran's president begins a rare visit to Africa 'to promote economic diplomacy'

Dramatically reducing cancer deaths requires the PASTEUR Act

Humana, CVS hope to turn members into patients at clinics

How are insurers handling Leqembi and related scans?

Grail's uphill battle for Medicare to cover its cancer screening test

entertainment

hotspot

entertainment

New air purifier tech could be key to improving indoor air quality

After half a century, Israel moves to evict squatter from his cave home on the beach

Drug repurposing or repositioning? The language matters

Trump drops motion seeking removal of DA probing efforts to overturn 2020 election in Georgia

Anesthesiologist group: stop taking Ozempic before surgery

For BCIs, commercial hurdles may be bigger than scientific ones

Alkermes shareholders re

White House drug shortage group privately met with industry

Bright Health sells Medicare Advantage business to Molina

What the cancer research community can learn from the Covid response

explore

France's anti

The debate over Covid

Grail's uphill battle for Medicare to cover its cancer screening test

Microsoft strikes partnership with Duke Health to advance health AI

2 US Navy sailors arrested for allegedly spying for China

Sickle cell gene therapy cures need to be accessible in Africa

entertainment

Wikipedia

hotspot

entertainment